dexpanthenol + nicotinamide + pyridoxine + riboflavin + thiamine: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
dexpanthenol + nicotinamide + pyridoxine + riboflavin + thiamine: clinical details
Prescribing considerations
- Confirm a plausible deficiency or prevention indication rather than using the combination non-specifically for fatigue.
- Review concurrent vitamin products to avoid unnecessary duplication.
- Check the exact levodopa formulation before prescribing or supplying.
Contraindications and cautions
- Hypersensitivity to any active ingredient or excipient.
Monitoring
- No product-specific routine laboratory monitoring is specified.
- Reassess the diagnosis and continued need if the expected clinical response is absent.
Clinical pharmacology
The ingredients act as coenzyme precursors or cofactors in energy metabolism, oxidation–reduction reactions, haemoglobin formation and coenzyme A-dependent metabolism. Excess water-soluble vitamins are eliminated mainly in urine.
Formulation and product differences
- The product is a clear yellow oral syrup.
- It contains sorbitol, propylene glycol, orange flavour and hydroxybenzoate preservatives.
- Protect it from light and follow the labelled storage temperature.
dexpanthenol + nicotinamide + pyridoxine + riboflavin + thiamine interactions
Check all medicines and supplements to avoid duplication and the recognised pyridoxine–levodopa interaction.
Levodopa
Pyridoxine may reduce the effectiveness of levodopa used alone. Carbidopa or benserazide protects against this effect, so check the exact Parkinson’s product before use.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.